Free preview. Sign up free to see the team, full portfolio, ownership chain, and shareholding history.
Science Creates Ventures 2a Lp investment portfolio
Science Creates Ventures 2a Lp has made numerous investments in companies such as Scarlet Therapeutics, Delta G, and Phovir Technologies within the Biotech sector.
vc
Portfolio
6
Team
0
Portfolio (6)
| Company | Sector | City | Source | Last confirmed on |
|---|---|---|---|---|
| Bitrobius Genetics Ltd Bitrobius Genetics develops the Gentrafix™ platform, a plasmid‑based technology that delivers therapeutic DNA to every affected cell through intercellular transmission, aiming to treat genetic diseases, including those caused by mitochondrial gene mutations. The company targets the gene‑therapy market for diseases that currently have no effective treatments. | Healthcare & Life Sciences | Macclesfield | Confirmed | 2025-11-23 |
| Delta G Limited DELTA G LIMITED is a UK-based quantum sensing company that develops quantum gravity sensors and gravity sensing hardware. Their primary product is a quantum gravity gradiometer, an underground imaging system that uses quantum technology to measure gravity gradients for accurate mapping and navigation. The company targets sectors such as infrastructure, transportation, energy, and defense, providing spatial intelligence for subsurface imaging, navigation, and environmental monitoring in various environments, including those where GPS is unavailable. | Industrials & Manufacturing | Birmingham | Confirmed | 2026-02-27 |
Shareholding changes (6)
Science Creates Ventures 2a Lp's positions across portfolio companies2026
- SERIES A1 PREFERRED 0 → 3,199
- SERIES A2 PREFERRED 0 → 1,184
- ORDINARY B2 SHARES 0 → 140,691
Articles (2)
- 18 Jun 2026
- Scarlet Therapeutics secures £3.5m for metabolic disease platform9 May 2026Scarlet Therapeutics